Back to my company list

New

Homox

The AI engine Fit Assessment

Beta

The company delivers drug development simulations and supports pharmaceutical R&D with Personal Digital Twin technology, enabling real-time monitoring, predictive analytics, and drug development workflows for pharma applications.

Blurb

Developer of a healthcare platform utilizing Personal Digital Twin technology for personalized health management. The platform integrates AI, IoT, blockchain, machine learning, and genetic analysis to create individualized health profiles. The company offers real-time health monitoring, predictive analytics, wearable device integration, and telehealth functionalities, serving healthcare providers, pharmaceutical companies, researchers, and individual users. Additional features include drug development simulations, fitness plan customization, virtual health assessments, and API integrations for health technology applications.

HQ Location

Tehran (Iran)

Founded

2023

Employees

1 - 10

Total funding raised

Not available

Funding Status

Not available

At Homox, we're pioneering the future of personalized healthcare. Our innovative approach leverages cutting-edge technologies like Artificial Intelligence, IoT, and Genetic Analysis to create dynamic Personal Digital Twins for individuals. These twins adapt and evolve with real-time health data, offering insights, predictions, and personalized interventions. Join us on LinkedIn to stay informed about the latest advancements in personalized medicine, healthcare technology, and our mission to empower individuals to take control of their health like never before. Welcome to the healthcare revolution with Homox.